Marked Improvement in Nail Psoriasis during Treatment with Adalimumab. Dermatology (Basel, Switzerland) [Dermatology] Journal article | | Title | Marked Improvement in Nail Psoriasis during Treatment with Adalimumab. | | Author(s) | Irla N, Yawalkar N | | Institution | Department of Dermatology, Bern University Hospital and University of Bern, Bern, Switzerland. | | Source | Dermatology 2009 Oct 23. | | Abstract | Background: Nail involvement is known as a common finding in psoriatic patients and represents a significant impact on patients' quality of life. The treatment of nail psoriasis is often challenging, and there is a need for new therapeutic options. Biologicals effective in the treatment of moderate to severe chronic plaque psoriasis may represent a new therapeutic modality for this disease. Adalimumab is a fully human IgG1 monoclonal antibody that binds to tumor necrosis factor alpha with high affinity and specificity. Observations: We report two cases of rapid improvement in nail psoriasis under adalimumab monotherapy with maintained effectiveness despite intermittent treatment as well as long remission after therapy discontinuation.
Conclusion: The marked improvement of our two cases indicates that adalimumab may also help ameliorate nail psoriasis and warrants further controlled studies to establish the effectiveness and therapeutic regimes. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19851059 |
|
|
| |
Advertise on this site.
| | |
|
